Pablo
Irimia Sieira
Consultor Médico
University of Parma
Parma, ItaliaUniversity of Parma-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2024
-
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Journal of neurology, neurosurgery, and psychiatry, Vol. 95, Núm. 10, pp. 927-937